TY  - SOUND
AU  - Crowe,James E.
TI  - SARS-COV-2 human monoclonal antibody therapy update
T2  - Interviews on Covid-19,
PY  - 2021///
CY  - London
PB  - Henry Stewart Talks
KW  - Antiviral agents
KW  - Development
KW  - Coronavirus infections
KW  - Chemotherapy
KW  - Immunological aspects
KW  - COVID-19 (Disease)
KW  - Research
KW  - Treatment
KW  - Drug development
KW  - Monoclonal antibodies
KW  - Therapeutic use
KW  - Antibodies, Monoclonal
KW  - pharmacology
KW  - therapeutic use
KW  - Antibodies, Neutralizing
KW  - Antiviral Agents
KW  - Betacoronavirus
KW  - drug effects
KW  - COVID-19
KW  - drug therapy
KW  - immunology
KW  - Drug Discovery
KW  - Immunotherapy
KW  - Neutralization Tests
KW  - Pandemics
KW  - SARS-CoV-2
N1  - Audio interview; Title from title frames; Contents: Review of the research done since the start of the pandemic -- Current work covering the SARS-CoV-2 variants -- The selection process of monoclonal antibodies for development -- Next steps in the research and future strategies -- The AHEAD100 project i.e. generating neutralizing antibodies for the 100 most likely causes of future epidemics; Access restricted to subscribers
UR  - https://hstalks.com/bs/4675/
UR  - https://hstalks.com/bs/p/1060/
ER  -